New

Create, analyze, optimize your ETF portfolio. Start now →

Advertisement
Advertisement

PTHvsARKGETF Comparison

ETF 1
PTH

Invesco DWA Healthcare Momentum ETF

This fund is part of
US Health Care
-1.08%
VS
ETF 2
ARKG

ARK Genomic Revolution ETF

This fund is part of
BioTech & Genomics
-0.67%

Invesco DWA Healthcare Momentum ETF (PTH) belongs to the US Health Care segment. ARK Genomic Revolution ETF (ARKG) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Health Care. PTH is less expensive with a Total Expense Ratio (TER) of 0.72%, versus 0.75% for ARKG. PTH is up 4.86% year-to-date (YTD) with -$6M in YTD flows. ARKG performs worse with 1.21% YTD performance, and -$39M in YTD flows. Run a side-by-side ETF comparison of PTH and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PTH vs ARKG performance and flow charts

Performance

-5051015%Mar 24Mar 31Apr 8Apr 15Apr 22

Cumulative Flows

-60 M-40 M-20 M0 M20 M40 MMar 24Mar 31Apr 8Apr 15Apr 22

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/24/2026
1M3MYTD1Y3Y5Y
Perf.
PTH
ARKG
+12.30%+11.02%
+6.29%-9.12%
+4.86%+1.21%
+38.78%+31.48%
+31.58%-2.03%
+0.54%-67.83%
Flows
PTH
ARKG
-$2M-$2M
-$5M-$134M
-$6M-$39M
-$10M-$94M
-$81M-$617M
-$357M-$3.04B
Volatility and drawdown
3M1Y3Y5Y
Volatility
PTH
ARKG
+26.84%+42.72%
+22.82%+41.46%
+24.56%+42.56%
+25.26%+45.35%
Max drawdown
PTH
ARKG
-7.51%-23.75%
-11.91%-27.52%
-29.24%-51.98%
-50.10%-80.16%
Max drawdown duration
PTH
ARKG
40d88d
140d92d
271d1010d
1695d1760d
Trading data

Create an account to view trading data

Join for free
PTH
ARKG
Last sale
4/24/2026 at 1:30 PM
$52.13
$29.54
Previous close
04/24/2026
$52.31
$29.80
Consolidated volume
04/24/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of March 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

ARKG
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
PTH
ARKG
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 4/24/2026 at 1:30 PM
Live
Closed
PTH
ARKG
Last price
$52.13
$29.54
1D performance
-0.34%
-0.87%
AuM$125.11 M$1.15 B
E/R0.72%0.75%
Characteristics
PTH
ARKG
Management strategyPassiveActive
ProviderInvescoArk Investment
BenchmarkDorsey Wright Healthcare Technical Leaders Index-
N° of holdings4627
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateOctober 12, 2006April 2, 2019
ESGNoNo
Advertisement
Exposure

Countries

PTH
USA
94.53%
Other
5.47%
ARKG
USA
70.4%
Switzerland
9.23%
Other
20.37%

Sectors

PTH
Health Care
85.2%
Other
14.8%
ARKG
Health Care
78.38%
Other
21.62%
Advertisement

Diversification

PTH

Total weight of top 15 holdings out of 15

52.67%
ARKG

Total weight of top 15 holdings out of 15

62.5%

Top 15 holdings

Data as of March 31, 2026
PTH
TERNS PHARMACEUTICALS
6.73%
ROIVANT SCIENCES LTD
5.47%
US74006W2070
5.15%
ARROWHEAD PHARMACEUTICALS INC
3.66%
GUARDANT HEALTH INC
3.47%
REVOLUTION MEDICINES INC
3.32%
TENET HEALTHCARE
3.16%
UTD THERAPEUT
2.99%
NATERA
2.95%
HCA HEALTHCARE
2.89%
CELCUITY INC
2.88%
AXSOME THERA CMN STK
2.58%
MADRIGAL PHARMACEUTICALS INC
2.58%
PROTAGONIST THERAPEUTICS INC
2.43%
COGENT BIOSCIENCES
2.40%
ARKG
CRISPR THERAPEUTICS
9.23%
10X GENOMICS INC
6.30%
BEAM THERAPEUTICS
4.86%
PERSONALIS INC
4.69%
NATERA
4.48%
ILLUMINA
4.45%
GUARDANT HEALTH INC
4.21%
INTELLIA THERAPEUTICS INC
3.58%
CAREDX INC/D
3.56%
RECURSION PHARMACEUTICALS
3.54%
ABSCI
3.27%
VERACYTE INC/D
2.98%
ADAPTIVE BIOTECHNOLOGIES
2.71%
NURIX THERAPEUTICS
2.45%
SEMA4 HOLDINGS CORP
2.19%
Frequently asked questions about PTH and ARKG

How have the PTH and ARKG ETFs performed in 2026?

As of April 24, 2026, PTH is up 4.86% year-to-date (YTD), while ARKG has returned 1.21%. That puts PTH better performer ahead so far this year.

Which ETF is attracting more investor money: PTH or ARKG?

Year-to-date, the PTH ETF saw -$6M in flows, compared to -$39M for ARKG.

Which ETF is more volatile: PTH or ARKG?

Over the past year, PTH had a volatility of 22.82%, while ARKG experienced 41.46%.

Which ETF is bigger: PTH or ARKG?

As of April 24, 2026, PTH holds $125.11 M in assets under management (AUM), while ARKG manages $1.15 B.

What sectors do the PTH and ARKG ETFs invest in?

PTH leans toward sectors like Health Care. Meanwhile, ARKG focuses on Health Care.

What are the top holdings of the PTH ETF and ARKG ETF?

PTH top holdings include TERNS PHARMACEUTICALS, ROIVANT SCIENCES LTD and US74006W2070. ARKG holds in its top three: CRISPR THERAPEUTICS, 10X GENOMICS INC and BEAM THERAPEUTICS.

Which ETF is more diversified: PTH or ARKG?

PTH holds 57 securities with 52.67% of its assets in the top 15. ARKG has 27 securities and a top 15 weight of 62.5%.

Advertisement
Latest news about PTH & ARKG
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up